MedTrace Logo

Effect of Socheongryong-tang and Yeongyopaedok-san in Upper Respiratory Tract Infection

NCT01019889 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 480

Last updated 2012-04-06

No results posted yet for this study

Summary

The purpose of this study is to determine whether Socheongryong-tang (SCRT) and Yeongyopaedok-san (YPS) are effective in the treatment of upper respiratory tract infection.

Conditions

  • Upper Respiratory Tract Infections

Interventions

DRUG

SCRT

4 capsules,three times daily, for 7days or within symptom disappearance

DRUG

YPS

4 capsules, three times daily, for 7days or within symptom disappearance

DRUG

Placebo

4 capsules, three times daily, for 7days or within symptom disappearance

Sponsors & Collaborators

  • Korea Health Industry Development Institute

    lead OTHER_GOV

Principal Investigators

  • YangChun Park, Ph. D. · Daejeon University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2009-06-30
Completion
2009-07-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01019889 on ClinicalTrials.gov